Supreme court throws Novartis a lifeline for Gilenya defense
generic, Gilenya, HEC Pharma, litigation, multiple sclerosis, Novartis, patent, patent litigation
0 Comment
patent litigation
Astellas facing generics to big-selling Lexiscan product in US
Amphastar, Astellas, generic, Glenmark, Hospira, Lexiscan, litigation, patent litigation
0 Comment
Court won’t raise Seagen damages award in Enhertu patent dispute
AstraZeneca, Daiichi Sankyo, Enhertu, patent litigation, Seagen
0 Comment
Teva asks SCOTUS to overturn “skinny label” verdict on GSK drug
generic, GlaxoSmithKline, patent litigation, SCOTUS, Teva
0 Comment
BioNTech bites back after CureVac patent challenge
BioNTech, Comirnaty, coronavirus, COVID-19, COVID-19 vaccine, CureVac, Moderna, patent litigation, Pfizer, Spikevax
0 Comment
Pfizer seeks to overturn three RSV vaccine patents held by GSK
GlaxoSmithKline, patent litigation, Pfizer, respiratory syncytial virus, vaccine
0 Comment
Enanta lawsuit claims Pfizer’s Paxlovid infringes its patent
antiviral, coronavirus, COVID-19, Enanta Pharmaceuticals, patent litigation, Paxlovid, Pfizer
0 Comment
Novartis faces threat of early generic of MS drug Gilenya in US
generics, multiple sclerosis, Novartis, patent litigation
0 Comment
1 2